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Abstract A reversible two-step (native stateHdenatured state)
folding mechanism based on equilibrium and stopped £ow ex-
periments is proposed for urea denaturation of the lipoyl-bear-
ing domain (hbLBD) of human mitochondrial branched chain
K-ketoacid dehydrogenase (BCKD) complex. The results from
this circular dichroism (CD) and £uorescence study have ruled
out populated kinetic or equilibrium intermediates on folding
pathway of this L-barrel domain under experimental conditions.
Both studies suggested mono-exponential kinetics without any
burst phases. Moreover the thermodynamic parameters vGH2O
and m obtained from the kinetic analysis are consistent with the
equilibrium measurements.
) 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Recent years have seen much e¡orts and anticipation to-
ward understanding the folding phenomenon of all L-sheet
proteins. Many single domain proteins from this subclass
have been identi¢ed to fold by an apparent two-step mecha-
nism [1^8]. Interestingly only a few of them like the small
L-barrel cold shock proteins (CspA and CspB) have true
two-step kinetics and fast folding capabilities [1,2,4]. Most
of the medium size proteins like those with L-trefoil topology
are found to have transient intermediates and slow folding
rates [7^10]. Collectively, these studies have casted doubt on
the notion that populated intermediates along the folding
pathway are necessary for e⁄cient folding. The folding mech-
anism of small proteins lacks signi¢cant kinetic traps and
perhaps is similar to early folding events of their larger coun-
terparts. The observation that folding can occur without a
well-de¢ned pathway of populated intermediates has provided
support for the new view of protein folding which emphasizes
energy landscapes and multiple paths over single pathway
[11,12]. Thus model systems with an ideal two-step mechanism
are highly sought for better understanding of the folding
mechanism.
K-Ketoacid dehydrogenase complexes are multienzyme as-
semblages generally made up of at least three main enzymes.
These complexes are also known to have remarkable structur-
al and functional similarities [13,14]. Among these complexes,
the human mitochondrial branched chain K-ketoacid dehy-
drogenase (BCKD) consists of three main catalytic compo-
nents: a hetero-tetrameric (K2L2) branched chain K-ketoacid
decarboxylase (E1), a homo-24meric dihydrolipoyl transacy-
lase (E2) and a homo-dimeric dihydrolipoamide dehydroge-
nase (E3). These enzymes act in tandem and are responsible
for catalyzing the oxidative decarboxylation of branched
chain K-ketoacids derived from leucine, isoleucine and valine
[15]. The branched chain acyl-CoAs formed in this reaction
are further channeled into the Krebs cycle or linked to lipid
and cholesterol biosynthesis. In patients with inherited maple
syrup urine disease (MSUD) the activity of the BCKD com-
plex is de¢cient. This results in the accumulation of branched
chain K-ketoacids and leads to severe clinical consequences
including fatal ketoacidosis, neurological derangement and
mental retardation in survivors [16]. The transacylase or E2
component plays an important dual role in proper structural
assembly as well as catalytic activity of BCKD. It consists of
three independently folded domains viz. the lipoyl-bearing
domain (hbLBD), the E1/E3 binding domain and the inner
core domain. hbLBD is an 84 amino acid, small L-barrel
domain. It hosts the active site lysyl residue responsible for
‘swinging arm’ coupling mechanism [17] and thus plays a cen-
tral role in substrate channeling in this mitochondrial complex
[18^20]. Recently we have determined the nuclear magnetic
resonance (NMR) solution structure of hbLBD and found it
to be a £attened L-barrel formed by two four-stranded
L-sheets (Fig. 1) [20]. It has a sole tryptophan residue, which
is advantageous as an intrinsic £uorescence probe to study
conformational changes. In the present investigation we re-
port kinetics of urea denaturation using circular dichroism
(CD) and £uorescence measurements for this interesting do-
main.
2. Materials and methods
2.1. Reagents
Specially prepared reagent grade urea was purchased from Nacalai
Tesque Inc., Japan. Stock urea solution was prepared daily, ¢ltered
and degassed by sonication before use. The molarity of urea was
determined by refractive index measurements [21]. All solutions
were prepared in 50 mM potassium phosphate bu¡er of pH
7.5H 0.1 containing 100 mM sodium chloride.
2.2. Protein preparation
An expression plasmid (pET28hLBD-His) was transformed in
BL21(DE3) strain of Escherichia coli under the control of T7 pro-
moter. To facilitate protein expression and puri¢cation the recombi-
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nant domain was constructed to contain a total of 93 amino acids
including an extra methionine residue at the N-terminus and a leucine,
a glutamic acid along with six histidines at the C-terminus. The pro-
tein was ¢rst puri¢ed by Ni-nitrilotriacetic acid (NTA) a⁄nity chro-
matography and then by fast protein liquid chromatography (FPLC)
using Sephacryl S-100 column. Its purity was found to be more than
95% by gel electrophoresis. The concentration of protein was deter-
mined from its molar extinction coe⁄cient of O280 = 12 090.
2.3. Equilibrium studies
All titration experiments were carried out with 6 WM hbLBD in 1.0
cm quartz square cuvettes thermostated to 22.0H 0.1‡C at constant
pH 7.5H 0.1. Aviv CD spectrometer model 202 with temperature and
stir control units in conjugation with auto titrator was used for fol-
lowing ellipticity changes at 228 nm (bandwidth 1 nm and averaging
time 1 s). Fluorescence measurements were done manually on Hitachi
F-4500 £uorescence spectrophotometer with excitation and emission
wavelengths of 295 and 320 nm respectively (slit width 2.5 nm and
scan speed 1 nm/s). The equilibrium unfolding data were normalized
after baseline correction to give the fraction of unfolded (Fu) and
analyzed for two-state model by non-linear regression assuming a
linear dependency of vGH2O (unfolding free energy) and m (degree
of hydrophobic exposure upon unfolding) on urea concentration [22].
Fu ¼ e
3ðvGH2O þmW½ureaÞ
RT
 
1þ e
3ðvGH2O þmW½ureaÞ
RT
  ð1Þ
2.4. Kinetics studies
Stopped £ow kinetics measurements were made on Aviv CD spec-
trometer model 202 with stopped £ow accessory having simultaneous
CD and £uorescence data collection capabilities of variable data col-
lection rates. All experiments were performed at 22.0H 0.1‡C and
pH 7.5H 0.1 by single denaturant concentration jump technique.
The kinetics was followed separately for ellipticity changes at 228
nm and £uorescence intensity changes for excitation at 295 nm using
cut o¡ ¢lter of 320 nm. The bandwidth of 2 nm was used in both
measurements. The dead time of mixture assembly was determined by
the test reaction between 8-hydroxyquinoline and magnesium ion [23].
Urea refolding reactions were initiated by a 10-fold dilution of
7.94 M urea denatured hbLBD solution with appropriate urea/bu¡er
solution to give the desired ¢nal concentration. Unfolding reactions
were conducted similarly by dilution of native hbLBD to desired high-
er urea concentration. The ¢nal concentration of protein was 30 WM
in all experiments. No amplitude changes were observed in the dead
time (V2.4 ms) of the instrument. The resulting folding and unfolding
traces were averaged (minimum of ¢ve) and analyzed for exponential
growth/decay by non-linear least squares algorithm. The logarithm of
the observed rates (kobs) was plotted as a function of urea concentra-
tion and analyzed for two-step kinetics by non-linear regression [24].
ln kobs ¼ ln krðH2OÞWeðmr W½urea=RTÞ þ kuðH2OÞWeðmu W½urea=RTÞ
n o
ð2Þ
where krðH2OÞ and kuðH2OÞ are the refolding and unfolding rate con-
stants in the absence of urea. mr and mu represent the dependency of
refolding and unfolding rates on urea concentration.
3. Results and discussion
The CD spectrum of hbLBD, shown in Fig. 2, insert A, has
a prominent positive ellipticity centered at 228 nm with a
small shoulder around 205 nm. The presence of a strong pos-
itive band at 228 nm may be attributed to the presence of
hydrophobic clustering of aromatic amino acids, as shown
in Fig. 1 [25]. This band shows negative ellipticity on dena-
turation. There is an isosbestic point at 202 nm for spectra
collected at di¡erent urea concentrations. The CD spectrum
of the folded hbLBD is unusual in that it lacks a minimum at
218 nm that would be expected for a L-sheet protein [25].
Nevertheless, the composite signal at 228 nm representing sec-
ondary and, to a lesser extent, tertiary structural changes can
be used to follow global changes in folding environment of
hbLBD. The urea-induced unfolding pro¢le for LBD (Fig. 2),
as monitored by ellipticity changes at 228 nm, shows that the
protein is completely unfolded at urea concentrations greater
than 7 M urea. This transition is completely reversible (data
not shown). The half-denaturation urea concentration is esti-
mated at 5.10 H 0.03 M. The m value, which is a measure of
hydrophobic exposure, was found to be 31.13H 0.02 kcal
mol31 M31. The free energy change for unfolding of hbLBD
in the absence of urea, vGH2O, is calculated as 5.73H 0.12 kcal
mol31.
Fig. 1. Ribbon representation of the structure of hbLBD (PDB code: 1k8m), created with InsightII program (Accelrys, San Diego, CA, USA).
The domain is a £attened L-barrel comprising of two four-stranded L-sheets. All aromatic residues, residues involved in missense mutation and
the hydrophobic residues surrounding Trp24 are also shown. The amino acids are labeled according to sequence given in the PDB ¢le.
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The £uorescence of hbLBD on excitation at 280 nm has a
typical protein emission hump at 320 nm (Fig. 2, insert B).
This band shows a batho-chromic shift to 350 nm on unfold-
ing. This can be mainly attributed to decrease in quenching of
the sole tryptophan residue with a minor contribution from
¢ve tyrosine residues in hbLBD sequence since little e¡ect on
the £uorescence emission was observed when the sample was
excited at 295 nm. The large blue shift upon folding re£ects
the extreme hydrophobicity of the Trp24 (PDB structure se-
quence) environment (Fig. 1). The titration curve, as shown in
Fig. 2, is almost superimposable with that measured by CD.
The half-denaturation urea concentration was 5.22H 0.08 M.
The m value and vGH2O were evaluated as 30.98H 0.06 kcal
mol31 M31 and 5.14H 0.30 kcal mol31. They are in good
agreement with values obtained by CD. These results strongly
suggested that there is no populated equilibrium intermedi-
ate(s) in unfolding pathway of hbLBD and the urea-induced
equilibrium denaturation of hbLBD follows a two-step (native
stateHdenatured state) mechanism.
We used stopped £ow kinetics to detect the presence of
transient intermediates. The results of hbLBD unfolding and
refolding as monitored by far-ultraviolet (UV) CD and £uo-
rescence are shown in Fig. 3A and B, respectively. The com-
plete signal evolution required nearly 50 s. There are no burst
phase ellipticity or £uorescence changes associated with this
transition. Traces for both probes can be satisfactorily ¢tted
to single exponential by non-linear regression. The F-test anal-
ysis suggested this to be a mono-exponential process and our
observation of residuals of ¢t supported this conclusion.
The observed rate constant (kobs) for complete unfolding
of hbLBD by single urea concentration jump to 7.99 M
was found to be 0.068H 0.001 s31 by both methods. The
observed rate constant for similar refolding experiment
from 7.94 M urea denatured hbLBD was 0.25 H 0.01 s31
Fig. 2. Urea denaturation of hbLBD at pH 7.5 and 22‡C as followed by CD (V=228) (F) and £uorescence (Vex = 295; Vem = 320) (a). The ¢ts
to Eq. 1 are shown by solid and dotted line respectively. The half-denaturation urea concentrations for hbLBD were found to be 5.10 and
5.22 M by far-UV CD and £uorescence respectively. Inserts: A: CD spectra of hbLBD in the presence of 0 M (solid line), 2 M (dotted line),
4 M (dashed line), 5 M (dash dot line), 6.25 M (dash dot dot line) and 7.5 M (bold dotted line) urea. B: Fluorescence emission spectra of na-
tive (solid line) and denatured (dotted line) hbLBD with excitation wavelength of 280 nm. All spectra were recorded at pH 7.5 and 22‡C.
Table 1
Summary of equilibrium and kinetic data for hbLBD
Method vGH2O
(kcal mol31)
m
(kcal mol31 M31)
krðH2OÞ
(s31)
mr
(kcal mol31 M31)
kuðH2OÞ
(U1033 s31)
mu
(kcal mol31 M31)
Equilibrium CD 5.73( H 0.12) 31.13( H 0.02) ^ ^ ^ ^
Equilibrium £uorescence 5.14( H 0.30) 30.98( H 0.06) ^ ^ ^ ^
Kinetic CDa 4.73( H 0.04) 30.89( H 0.03) 0.49(H 0.03) 30.44(H 0.02) 0.15(H 0.04) 0.45(H 0.02)
Kinetic £uorescencea 4.17( H 0.04) 30.88( H 0.03) 0.39(H 0.03) 30.48(H 0.03) 0.32(H 0.08) 0.39(H 0.02)
avGH2O =3RT ln(kuðH2OÞ/krðH2OÞ) ; m=mr3mu.
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and 0.21H 0.00 s31 by far-UV CD and £uorescence respec-
tively. These values though are in perfect agreement within
experimental errors. They account for a refolding time con-
stant of 4.3 s (averaged value) for hbLBD. This value is in
good agreement with the fast phase of previously reported
L-trefoil proteins. The equilibrium studies on the folding of
this subclass of proteins suggested a two-step mechanism
[5^8], but except a recent report on hisactophilin [5] most of
the other members of this subclass have kinetic intermediates
on folding pathway [8^10].
In order to establish the rigorous kinetic criteria of a two-
step mechanism, we analyzed the logarithm of observed rate
constant, ln kobs, as a function of urea concentration using
Eq. 2 (Fig. 4). Our results showed a linear relationship be-
Fig. 3. Unfolding (A) and refolding (B) stopped £ow traces for hbLBD following a 10-fold dilution. The CD (E) and £uorescence (a) data
were acquired simultaneously in four time domains of varying data collection rates ranging from 1000 points/S (t6 20 s) to 10 points/s
(ts 20 s). The mono-exponential ¢t for CD (V=228) is shown by solid line while that for £uorescence (Vex = 295; Vem6 320) by dotted line.
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tween logarithm of rate constant and denaturant concentra-
tion. The resulting ¢t resembles a perfect ‘V’ shape. Moreover
the results from far-UV CD are in good agreement with those
from £uorescence analysis. This indicates concomitant recov-
ery of both secondary and tertiary structures of hbLBD. All
these observations strongly suggested a two-step kinetics with-
out any populated transient intermediates. The kinetic param-
eters are summarized in Table 1. The apparent equilibrium
stability, vGH2O, estimated from the ratio of refolding and
unfolding rate constants agrees within experimental error
with the equilibrium analysis. The m value from both probes
is also in good agreement with the value deduced from equi-
librium analysis. This is an additional and strong proof for
two-step kinetics of hbLBD.
hbLBD from BCKD, as well as from pyruvate dehydroge-
nase complex (PDC), are M2 auto antigens in patients with
primary biliary cirrhosis. Nearly 63 mutations, a majority of
which a¡ect E1K or E2 loci, are identi¢ed in BCKD complex
gene of MSUD patients [14]. There are six missense mutations
(E28del, I38M, P74R, P74L, D77Y, and I78t) detected in the
hbLBD that a¡ect stability of the E2 subunit and are without
e¡ect on lipoic acid incorporation in hbLBD [16]. The hbLBD
structure shows that the two residues Ile38 and Ile78 are buried
inside the hydrophobic core and are likely to contribute sig-
ni¢cantly to the stability of the domain. Therefore, the patho-
logical consequence of these two mutations could potentially
be due to the e¡ect on stability and folding of the molecule.
The other three mutated residues are surface residues on sheet
S2. Pro74 is the ¢rst residue in strand 8. Due to the unique
backbone structure in proline, a mutation in this residue can
have signi¢cant e¡ect on the overall folding. Glu28 is located
in the loop between strands L2 and L3. An in-frame deletion
in the residue results in the absence of E2 protein (data not
shown), suggesting this residue also has profound e¡ects on
folding of the E2 chain. Asp77 resides in the middle of
strand 8, and its side chain is also on the surface. Whether
the pathological e¡ect of this residue is due to its involvement
in recognition with other components of the BCKD complex
or due to perturbation on the protein folding remains to be
elucidated. The current work is instrumental in planning fu-
ture study to estimate consequences of these mutations on
folding and stability of hbLBD and its e¡ect on overall func-
tion of BCKD.
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